Tempest Therapeutics (TPST) Total Debt (2017 - 2025)

Tempest Therapeutics has disclosed Total Debt across 9 years of filings, most recently posting $8.4 million for Q1 2025.

• In Q1 2025, Total Debt fell 50.81% year-over-year to $8.4 million; the TTM figure through Mar 2025 stood at $8.4 million (down 50.81% YoY), while the FY2024 annual figure was $12.8 million, up 20.9% from the prior year.
• Total Debt came in at $8.4 million for Q1 2025 at Tempest Therapeutics, down from $12.8 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $19.3 million in Q2 2024 to a low of $8.4 million in Q1 2025.
• Average Total Debt over 5 years is $14.4 million, with a median of $15.0 million recorded in 2021.
• Year-over-year, Total Debt soared 6659.01% in 2021 and tumbled 50.81% in 2025.
• Over 5 years, Total Debt stood at $15.1 million in 2021, then slumped by 31.18% to $10.4 million in 2022, then gained by 1.72% to $10.5 million in 2023, then grew by 20.9% to $12.8 million in 2024, then tumbled by 34.22% to $8.4 million in 2025.
• Per Business Quant data, the three most recent Total Debt figures were $8.4 million in Q1 2025, $12.8 million in Q4 2024, and $17.0 million in Q3 2024.